To validate the clinical relevance of these exosomal miRNAs, we examined whether they are secreted into the blood of ER+ patients using the cohort data set of the circulating miRNA profiles from 23 ER+ breast cancer patients and 22 healthy donors (Fig. 1a). This evidence concerns the gene ESR1 and breast carcinoma.